Viewing Study NCT01231620


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:29 AM
Study NCT ID: NCT01231620
Status: COMPLETED
Last Update Posted: 2018-10-15
First Post: 2010-10-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01-15
Start Date Type: ACTUAL
Primary Completion Date: 2015-03-18
Primary Completion Date Type: ACTUAL
Completion Date: 2015-03-18
Completion Date Type: ACTUAL
First Submit Date: 2010-10-28
First Submit QC Date: None
Study First Post Date: 2010-11-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-04-11
Results First Submit QC Date: None
Results First Post Date: 2017-11-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2016-01-12
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2018-09-14
Last Update Post Date: 2018-10-15
Last Update Post Date Type: ACTUAL